Agile Therapeutics reported $123.59M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Aceto ACET:US $ 327.36M 88.33M
Adma Biologics ADMA:US $ 205.1M 10.57M
Agile Therapeutics AGRX:US $ 123.59M 59.99M
Antares Pharma ATRS:US $ 735.96M 42.2M
Bayer BAYN:GR 50.48B 2.53B
Biodelivery Sciences International BDSI:US $ 352.73M 38.5M
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Merk MRK:US $ 196918.18M 1780.24M
Pacira Pharmaceuticals PCRX:US $ 2.67B 402.93M
Pain Therapeutics PTIE:US $ 3.42B 1.62B
Pfizer PFE:US $ 219205.69M 17108.81M
Teva Pharmaceutical Industries TEVA:US 10.99B 1.56B
Therapeuticsmd TXMD:US 467.9M 51.79M